News GenoScreen Corporate
Service continuity during containment
Following the Government's announcements concerning the COVID-19 pandemic, we are pleased to inform you that we have taken the necessary measures to ensure that all of our activities are maintained while guaranteeing the safety for our employees.
GenoScreen participates in the Adebiotech’s Insectinov3 conference!
On November 26 and 27, GenoScreen will participate at the Adebiotech's conference on " Insect Production for Human and Animal Nutrition” at Biocitech Romainville-Grand Paris.
Publication of the first comprehensive performance evaluation of the "Deeplex® Myc-TB" test for the prediction of tuberculosis antibiotic resistance.
Press release - The innovative Deeplex® Myc-TB antibiotic resistance prediction test has been evaluated by an international research team. By analyzing data from more than 5,600 strains and samples of various origins and types, this study measures for the first time the sensitivity, specificity and detection limit of this test.
GenoScreen is joining the IAR cluster
GenoScreen is now joining the Industries & Agro-Resources (IAR) competitiveness cluster as a member.
GenoScreen, sponsor of "The Magnificent Last Decade In Genetics and Genomics"
GenoScreen is sponsor of the Genetics and Genomics Symposium organized by Equipex LIGAN-PM, entitled "The Magnificent Last Decade In Genetics and Genomics".
This symposium will take place on March 13, 2020 at the Faculty of Medicine of the University of Lille.
Program of the event :
GenoScreen is ISO 13485 certified
GenoScreen is ISO 13485 certified for the "design, development, manufacture, commercialization and distribution of in-vitro diagnostic kits".
GenoScreen welcomes a new doctor
Louise-Eva VANDENBORGHT supported her thesis for the degree of doctor of the University of Bordeaux
GenoScreen is certified "Illumina Propel"
GenoScreen joins the close circle of French companies certified "Illumina Propel"!